Novo Nordisk, maker of the blockbuster drugs for diabetes and weight loss respectively, has a market capitalisation of $592.02 billion, making it larger than the entire Danish economy. The company's global CEO talks about its India plans and the need for competition to ramp up innovation in pharma
Related Keywords
India , Denmark , Bengaluru , Karnataka , Danish , Eli Lily , Chris Ratcliffe Bloomberg , Nordisk Insulinlaboratorium , Novo Terapeutisk Laboratorium , Lars Fruergaard , Eli Lilly , Novo Nordisk , Novo Nordisk Foundation , World Health Organization , Forbes India , Big Pharma ,
comparemela.com © 2020. All Rights Reserved.